Deal follows publication of a study in the Journal of Radiotherapy and Oncology about the role of historical clinical insights in patient-specific decision making
SAN FRANCISCO–(BUSINESS WIRE)–Siris Medical, Inc., a company headquartered in Silicon Valley and Boston that offers the only Artificial Intelligence (AI) treatment decision-support system for use in radiation oncology, announced today that it has been awarded a contract with the University of California, San Francisco Department of Radiation Oncology. UCSF will implement Siris Medical’s QuickMatchTM software as a primary treatment decision support tool for the treatment of head, neck and lung cancer patients.
“This will help us leverage the wealth of our expertise and more efficiently choose the best treatment plan for each individual patient. I am thrilled to see the impact of this technology”
“This will help us leverage the wealth of our expertise and more efficiently choose the best treatment plan for each individual patient. I am thrilled to see the impact of this technology,” said Tim Solberg PhD, Vice Chair of the Department of Radiation Oncology at UCSF.
This announcement follows a recent publication, “Clinical decision support of radiotherapy treatment planning: A data-driven machine learning strategy for patient-specific dosimetric decision making,” in the Journal of Radiotherapy and Oncology in December 2017. This study demonstrates the unique ability of the platform to draw upon historical clinical insights for patient-specific decision making. QuickMatch software assists physicians, patients and payers alike to make better-informed decisions about treatment techniques, prescription and tradeoffs. The study was a collaborative effort between UCSF, University of Pennsylvania, University of Maryland, and Siris Medical.
Colin Carpenter PhD, President and CEO of Siris Medical adds: “We are excited to have the opportunity to support the expertise of the UCSF team. We are confident that QuickMatch will accelerate the treatment planning process and enable each patient to benefit from the best plan possible to treat their disease.”
UC San Francisco (UCSF) is a leading university dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care. It includes top-ranked graduate schools of dentistry, medicine, nursing and pharmacy; a graduate division with nationally renowned programs in basic, biomedical, translational and population sciences; and a preeminent biomedical research enterprise. It also includes UCSF Health, which comprises top-ranked hospitals, UCSF Medical Center and UCSF Benioff Children’s Hospitals in San Francisco and Oakland – and other partner and affiliated hospitals and healthcare providers throughout the Bay Area. Please visit www.ucsf.edu/news.
About QuickMatchTM Software
QuickMatch software utilizes artificial intelligence and the experience of historical treatments to give clinicians insight into the best achievable plan for each individual patient while eliminating the need for time consuming treatment planning iterations. QuickMatch software is the only radiotherapy treatment planning decision support product on the market.
About Siris Medical
Siris Medical empowers clinicians to achieve efficient high-quality cancer radiation treatment decisions through its proprietary artificial intelligence platform. Please visit www.siris-medical.com for more information.